COMMUNIQUÉS West-GlobeNewswire

ICC International Cannabis Corp. Competing in Explosive Worldwide Cannabis Market with Unique Global Strategy
22/02/2019
NEW YORK, NY, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Make no mistake about it the growth of the worldwide legal cannabis industry is exploding exponentially. One key driver behind this explosion is the many nations that have [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
22/02/2019
BURLINGTON, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two conferences in February. David Roberts, President, is scheduled to present [...]
Obalon Announces First Commercial Shipment of its Navigation Balloon Placement System with Touch Inflation Dispenser
22/02/2019
Obalon Navigation System™ with Touch™ Inflation Dispenser are intended to increase adoption of the Obalon Balloon by improving ease of administration and eliminating the need for x-ray imaging on placement SAN DIEGO, [...]
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
22/02/2019
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO ), a biotechnology acceleration company, announces multiple interviews with the company’s CEO, Denis Corin, and the Q BioMed team are now available [...]
Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference
22/02/2019
NEW YORK and CLEVELAND, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company developing novel cell and gene therapies for serious diseases, today [...]
Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZA™ (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis
22/02/2019
- Study will assess the impact of QBREXZA treatment on sweat severity in patients with primary palmar hyperhidrosis - Results will inform potential development plans for QBREXZA in primary palmar hyperhidrosis - [...]
Aptinyx to Present at 8th Annual SVB Leerink Global Healthcare Conference
22/02/2019
EVANSTON, Ill., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference
22/02/2019
PITTSBURGH, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
Alder BioPharmaceuticals® Submits Biologics License Application to the U.S. Food and Drug Administration for Eptinezumab
22/02/2019
Significant milestone toward the commercialization of eptinezumab, the first quarterly infusion therapy for migraine prevention BOTHELL, Wash., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: [...]
Calithera to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
22/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Obalon Announces Fourth Quarter and Full Year 2018 Financial Results
22/02/2019
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study
22/02/2019
Decreased HHV-6 Reactivation Observed Among Oral Brincidofovir Allogeneic Hematopoietic Cell Transplantation Recipients Results to be Presented at Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR 2019 [...]
Voyager Therapeutics and AbbVie Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies
22/02/2019
Deal expands collaborative efforts on vectorized antibodies to target pathological species of alpha-synuclein Voyager to receive $65 million upfront and up to $245 million in preclinical and Phase 1 option payments as [...]
Principia Biopharma Announces the Acceptance of Data from Phase 2 Pemphigus Vulgaris Trial as a Late-Breaking Presentation at 2019 American Academy of Dermatology Meeting
22/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Radient Technologies Inc. Files 17 Provisional Patent Applications for Innovating Cannabinoid Consumption Products and Devices
22/02/2019
EDMONTON, Alberta, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ; OTCQX: RDDTF ) is pleased to announce it has filed an additional 17 provisional patent [...]
Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders
22/02/2019
DUBLIN, Ireland and TREVOSE, Pa., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
TG Therapeutics, Inc. Announces Data Presentation at the Upcoming Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Annual Meeting
22/02/2019
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that the final Phase 2 data from the multicenter trial of ublituximab (TG-1101), the Company’s novel glycoengineered anti [...]
BrainStorm Announces First Contracted U.S. Clinical Site for Phase 2 Progressive MS Study
22/02/2019
Phase 2 Open-Label Trial of Autologous MSC-NTF Cell Therapy (NurOwn®) in Progressive MS Patients will Begin Enrollment in Early 2019 NEW YORK and CLEVELAND, Feb. 22, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics [...]
Vectra® Study Published in the Journal Current Medical Research & Opinion
22/02/2019
Vectra Test Significantly Outperforms DAS28-CRP and CRP and Is the Best Predictor of Joint Damage in Patients with Rheumatoid Arthritis SALT LAKE CITY, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: [...]

Pages